Services Provided for the Diagnosis and Treatment of Diabetic Sensory Neuropathy with Loss of Protective Sensation (aka Diabetic Peripheral Neuropathy) | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its coverage policy for services related to the diagnosis and treatment of diabetic sensory neuropathy with loss of protective sensation (also called diabetic peripheral neuropathy), with an effective date of May 15, 2026. Here's what billing teams need to know before that date.

This update touches a high-volume Medicare population. Diabetic peripheral neuropathy affects tens of millions of Medicare beneficiaries, and the foot care and neurological evaluation services tied to this diagnosis are billed across podiatry, primary care, endocrinology, and physical therapy. The policy does not list a specific policy code in CMS's numbering system. Because the full policy detail was not available at time of publication, the specific codes affected are not listed — but the clinical and billing implications of this coverage policy are substantial enough that your team should pull the source document before May 15, 2026.

CMS Diabetic Peripheral Neuropathy Coverage Criteria and Medical Necessity Requirements 2026

The CMS diabetic peripheral neuropathy coverage policy has been one of the more clinically specific Medicare coverage policies for years. It governs when Medicare will pay for foot care and evaluation services in patients with diabetes who have documented loss of protective sensation. The word "modified" matters here — this isn't a new policy. Something changed. Your team needs to know what.

Under the longstanding CMS framework, diabetic peripheral neuropathy billing requires documented evidence that the patient has diabetes, that sensory neuropathy with loss of protective sensation is present, and that the treating clinician performed a qualifying evaluation. Medical necessity is not assumed from a diabetes diagnosis alone. The documentation has to show the clinical picture explicitly.

The Centers for Medicare & Medicaid Services has historically required that a physician — or a qualified non-physician practitioner — document the neuropathy finding using objective clinical criteria. That often means monofilament testing, vibration threshold testing, or similar sensory evaluation tools. If your providers are checking the box on diagnosis without recording the actual sensory findings, denials will follow.

The modification effective May 15, 2026 may update those clinical thresholds, the required evaluation elements, or the documentation language CMS expects to see on the claim or in the medical record. Until the full policy text is confirmed, treat this as a trigger to audit your current documentation templates against whatever CMS has published at the source URL. If you don't know whether your current workflows satisfy the new standard, talk to your compliance officer before the effective date.

Prior authorization is not a feature of most Medicare fee-for-service coverage policies at the claim-submission level, but that doesn't mean coverage is automatic. Medical necessity must be established in the record, and CMS contractors will apply this coverage policy during post-payment review and prepayment audits. That's where the real exposure lives.

CMS Diabetic Peripheral Neuropathy Exclusions and Non-Covered Indications

The existing CMS coverage policy has always drawn a clear line between routine foot care and medically necessary foot care. That line is directly tied to the neuropathy documentation.

Routine foot care — nail trimming, callus removal, general hygiene — is explicitly non-covered for most Medicare patients. The diabetic peripheral neuropathy exception to that exclusion exists precisely because loss of protective sensation creates a genuine medical risk from what would otherwise be considered routine. If the neuropathy isn't documented, the exception doesn't apply. The claim denies.

This is the most common failure point in diabetic foot care billing. A provider performs medically necessary foot care on a patient with documented neuropathy, but the claim documentation doesn't connect those dots explicitly. CMS's medical necessity standard requires the connection to be stated — not implied.

Any service billed under this coverage policy without a corresponding neuropathy evaluation in the medical record is vulnerable. That includes evaluation and management services, foot care procedures, and any orthotic or therapeutic footwear claims that rely on the neuropathy diagnosis as the qualifying condition.

Coverage Indications at a Glance

Because the full updated policy text was not available at time of publication, this table reflects the established CMS coverage framework for diabetic peripheral neuropathy services. Verify against the May 15, 2026 version of the policy for any changes.

CMS Diabetic Peripheral Neuropathy Billing Guidelines and Action Items 2026

Here's what your billing and clinical teams should do before May 15, 2026.

CPT, HCPCS, and ICD-10 Codes for Diabetic Peripheral Neuropathy Services Under This CMS Policy

The policy data provided for this modification does not list specific CPT, HCPCS, or ICD-10 codes. Do not assume the code set from previous versions of this policy is unchanged — that's exactly the kind of assumption that creates claim denial exposure after a policy modification.

Pull the full policy document and confirm the applicable codes directly. Common code families associated with CMS diabetic peripheral neuropathy coverage policies historically include foot care procedure codes, office visit E/M codes with the neuropathy diagnosis, and HCPCS codes for therapeutic footwear — but this post will not list specific codes that haven't been confirmed in the updated policy text.

Your coding team should verify the complete code list against the May 15, 2026 effective policy before submitting any claims under this coverage framework post-update.